The American Society of Hematology and the Leukemia & Lymphoma Society Collaborate to Support Blood Cancer Patients

Recently, the American Society of Hematology, which is the biggest organization of hematologist research for better understanding of issues associated with the blood, and the Leukemia & Lymphoma Society, which is the most well-known health agency for people with blood cancer, have announced a combined initiative for patients of blood cancer and their families. More…

Read More

CryoLife Achieved CE-Mark For E-nay Stent Graft System To Repair Lesion Of Aortic Disease

CryoLife Inc. announced today that the company has received the CE Mark for E-nay stent graft system which is developed to repair the lesion of the descending thoracic aorta, thoracic aorta aneurysms, and related dissections. E-nay thoracic stent graft system will be developed in Hechingen, Germany at the company’s facility. The report was published in…

Read More

Experts Declare a Trial for Evaluating Efficiency of Contrast Enhanced Mammography for Women Having Dense Breasts

The ACR Centre for Research and Innovation recently arranged a planned trial for determining a preferable method for cancer detection in women with breast cancer. The research center has decided to compare two modes of cancer detection: Contrast enhanced spectral mammography – CESM and Digital Breast Tomosynthesis – DBT, and Whole Breast Ultrasound – WBUS,…

Read More

Chipscreen Bioscience’s Chidamide Gets Approval For Breast Cancer Indication

Recently, Chipscreen Biosciences Co., Ltd, which is a company that develops and specializes in medications that are based on small molecules, announced that its latest product, the Chidamide or Epidaza, has received approval for marketing in the second indication from the National Medical Products Administration. The Epidaza is an oral subtype-selective histone deacetylase (HDAC) inhibitor….

Read More

Publication Introduces Non-Invasive Testing for Aneuploidy Risks in Twin Pregnancies

Natera incorporation is a leading name in the genome testing facility, cell-free DNA testing, and it announced the results of successful Cell-free DNA testing in the Journal of Prenatal Diagnosis. The study demonstrated that the measurement of the single fetal fraction along with the zygosity under reporting offers a powerful insight into the precision and…

Read More